nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—Fatigue—Captopril—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Zanamivir—Myalgia—Leflunomide—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Zanamivir—Arthralgia—Leflunomide—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Zanamivir—Anxiety—Leflunomide—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Zanamivir—Discomfort—Leflunomide—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Zanamivir—Skin disorder—Azathioprine—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Zanamivir—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Zanamivir—Cough—Mycophenolic acid—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Zanamivir—Vomiting—Pentoxifylline—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Zanamivir—Convulsion—Mycophenolic acid—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Zanamivir—Rash—Pentoxifylline—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Zanamivir—Dermatitis—Pentoxifylline—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Zanamivir—Headache—Pentoxifylline—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Zanamivir—Face oedema—Prednisone—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Zanamivir—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Zanamivir—Feeling abnormal—Captopril—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Zanamivir—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Zanamivir—Myalgia—Mycophenolic acid—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Zanamivir—Infection—Leflunomide—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Zanamivir—Gastrointestinal pain—Captopril—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Zanamivir—Anxiety—Mycophenolic acid—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Zanamivir—Asthenia—Mometasone—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Zanamivir—Discomfort—Mycophenolic acid—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Zanamivir—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Zanamivir—Skin disorder—Leflunomide—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Zanamivir—Confusional state—Mycophenolic acid—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Zanamivir—Body temperature increased—Captopril—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Zanamivir—Abdominal pain—Captopril—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Zanamivir—Anorexia—Leflunomide—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Zanamivir—Nausea—Pentoxifylline—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Zanamivir—Chills—Mycophenolate mofetil—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Zanamivir—Malaise—Lisinopril—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Zanamivir—Infection—Mycophenolic acid—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Zanamivir—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Zanamivir—Diarrhoea—Mometasone—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Zanamivir—Syncope—Lisinopril—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Zanamivir—Shock—Mycophenolic acid—systemic scleroderma	0.002	0.002	CcSEcCtD
Zanamivir—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Zanamivir—Loss of consciousness—Lisinopril—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Zanamivir—Cough—Lisinopril—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Zanamivir—Anorexia—Mycophenolic acid—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Zanamivir—Arthralgia—Lisinopril—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Zanamivir—Myalgia—Lisinopril—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Zanamivir—Anxiety—Lisinopril—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Zanamivir—Dyspnoea—Leflunomide—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Zanamivir—Discomfort—Lisinopril—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Zanamivir—Vomiting—Mometasone—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Zanamivir—Feeling abnormal—Azathioprine—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Zanamivir—Rash—Mometasone—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Zanamivir—Asthenia—Captopril—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Zanamivir—Dermatitis—Mometasone—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Zanamivir—Decreased appetite—Leflunomide—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Zanamivir—Confusional state—Lisinopril—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Zanamivir—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Zanamivir—Headache—Mometasone—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Zanamivir—Fatigue—Leflunomide—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Zanamivir—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Zanamivir—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Zanamivir—Pain—Leflunomide—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Zanamivir—Infection—Lisinopril—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Zanamivir—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Zanamivir—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Zanamivir—Shock—Lisinopril—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Zanamivir—Neutropenia—Prednisone—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Zanamivir—Body temperature increased—Azathioprine—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Zanamivir—Abdominal pain—Azathioprine—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Zanamivir—Skin disorder—Lisinopril—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Zanamivir—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Zanamivir—Diarrhoea—Captopril—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Zanamivir—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Zanamivir—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Zanamivir—Feeling abnormal—Leflunomide—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Zanamivir—Fatigue—Mycophenolic acid—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Zanamivir—Nausea—Mometasone—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Zanamivir—Anorexia—Lisinopril—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Zanamivir—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Zanamivir—Pain—Mycophenolic acid—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Zanamivir—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Zanamivir—Cough—Mycophenolate mofetil—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Zanamivir—Dizziness—Captopril—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Zanamivir—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Zanamivir—Urticaria—Leflunomide—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Zanamivir—Body temperature increased—Leflunomide—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Zanamivir—Abdominal pain—Leflunomide—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Zanamivir—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Zanamivir—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Zanamivir—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Zanamivir—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Zanamivir—Hypersensitivity—Azathioprine—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Zanamivir—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Zanamivir—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Zanamivir—Vomiting—Captopril—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Zanamivir—Dyspnoea—Lisinopril—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Zanamivir—Rash—Captopril—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Zanamivir—Dermatitis—Captopril—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Zanamivir—Headache—Captopril—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Zanamivir—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Zanamivir—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Zanamivir—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Zanamivir—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Zanamivir—Asthma—Methotrexate—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Zanamivir—Infection—Mycophenolate mofetil—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Zanamivir—Decreased appetite—Lisinopril—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Zanamivir—Fatigue—Lisinopril—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Zanamivir—Shock—Mycophenolate mofetil—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Zanamivir—Hypersensitivity—Leflunomide—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Zanamivir—Pain—Lisinopril—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Zanamivir—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Zanamivir—Diarrhoea—Azathioprine—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Zanamivir—Haemoglobin—Prednisone—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Zanamivir—Nausea—Captopril—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Zanamivir—Haemorrhage—Prednisone—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Zanamivir—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Zanamivir—Asthenia—Leflunomide—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Zanamivir—Hallucination—Prednisone—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Zanamivir—Feeling abnormal—Lisinopril—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Zanamivir—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Zanamivir—Neutropenia—Methotrexate—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Zanamivir—Dizziness—Azathioprine—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Zanamivir—Asthenia—Mycophenolic acid—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Zanamivir—Diarrhoea—Leflunomide—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Zanamivir—Urticaria—Lisinopril—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Zanamivir—Abdominal pain—Lisinopril—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Zanamivir—Body temperature increased—Lisinopril—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Zanamivir—Vomiting—Azathioprine—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Zanamivir—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Zanamivir—Rash—Azathioprine—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Zanamivir—Dermatitis—Azathioprine—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Zanamivir—Headache—Azathioprine—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Zanamivir—Dizziness—Leflunomide—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Zanamivir—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Zanamivir—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Zanamivir—Pain—Mycophenolate mofetil—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Zanamivir—Arrhythmia—Prednisone—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Zanamivir—Vomiting—Leflunomide—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Zanamivir—Hypersensitivity—Lisinopril—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Zanamivir—Dizziness—Mycophenolic acid—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Zanamivir—Rash—Leflunomide—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Zanamivir—Dermatitis—Leflunomide—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Zanamivir—Nausea—Azathioprine—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Zanamivir—Headache—Leflunomide—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Zanamivir—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Zanamivir—Asthenia—Lisinopril—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Zanamivir—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Zanamivir—Vomiting—Mycophenolic acid—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Zanamivir—Haemoglobin—Methotrexate—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Zanamivir—Rash—Mycophenolic acid—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Zanamivir—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Zanamivir—Haemorrhage—Methotrexate—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Zanamivir—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Zanamivir—Headache—Mycophenolic acid—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Zanamivir—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Zanamivir—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Zanamivir—Nausea—Leflunomide—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Zanamivir—Diarrhoea—Lisinopril—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Zanamivir—Ill-defined disorder—Prednisone—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Zanamivir—Agitation—Prednisone—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Zanamivir—Dizziness—Lisinopril—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Zanamivir—Erythema multiforme—Methotrexate—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Zanamivir—Nausea—Mycophenolic acid—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Zanamivir—Malaise—Prednisone—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Zanamivir—Syncope—Prednisone—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Zanamivir—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Zanamivir—Loss of consciousness—Prednisone—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Zanamivir—Vomiting—Lisinopril—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Zanamivir—Rash—Lisinopril—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Zanamivir—Convulsion—Prednisone—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Zanamivir—Dermatitis—Lisinopril—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Zanamivir—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Zanamivir—Chills—Methotrexate—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Zanamivir—Headache—Lisinopril—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Zanamivir—Arthralgia—Prednisone—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Zanamivir—Myalgia—Prednisone—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Zanamivir—Anxiety—Prednisone—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Zanamivir—Discomfort—Prednisone—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Zanamivir—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Zanamivir—Nausea—Lisinopril—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Zanamivir—Anaphylactic shock—Prednisone—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Zanamivir—Infection—Prednisone—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Zanamivir—Shock—Prednisone—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Zanamivir—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Zanamivir—Skin disorder—Prednisone—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Zanamivir—Anorexia—Prednisone—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Zanamivir—Ill-defined disorder—Methotrexate—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Zanamivir—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Zanamivir—Rash—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Zanamivir—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Zanamivir—Headache—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Zanamivir—Malaise—Methotrexate—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000993	0.000993	CcSEcCtD
Zanamivir—Cough—Methotrexate—systemic scleroderma	0.000974	0.000974	CcSEcCtD
Zanamivir—Convulsion—Methotrexate—systemic scleroderma	0.000967	0.000967	CcSEcCtD
Zanamivir—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000955	0.000955	CcSEcCtD
Zanamivir—Arthralgia—Methotrexate—systemic scleroderma	0.00095	0.00095	CcSEcCtD
Zanamivir—Myalgia—Methotrexate—systemic scleroderma	0.00095	0.00095	CcSEcCtD
Zanamivir—Decreased appetite—Prednisone—systemic scleroderma	0.000947	0.000947	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000943	0.000943	CcSEcCtD
Zanamivir—Fatigue—Prednisone—systemic scleroderma	0.000939	0.000939	CcSEcCtD
Zanamivir—Discomfort—Methotrexate—systemic scleroderma	0.000939	0.000939	CcSEcCtD
Zanamivir—Confusional state—Methotrexate—systemic scleroderma	0.000918	0.000918	CcSEcCtD
Zanamivir—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000911	0.000911	CcSEcCtD
Zanamivir—Infection—Methotrexate—systemic scleroderma	0.000905	0.000905	CcSEcCtD
Zanamivir—Feeling abnormal—Prednisone—systemic scleroderma	0.000898	0.000898	CcSEcCtD
Zanamivir—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000891	0.000891	CcSEcCtD
Zanamivir—Skin disorder—Methotrexate—systemic scleroderma	0.000885	0.000885	CcSEcCtD
Zanamivir—Anorexia—Methotrexate—systemic scleroderma	0.000868	0.000868	CcSEcCtD
Zanamivir—Urticaria—Prednisone—systemic scleroderma	0.000866	0.000866	CcSEcCtD
Zanamivir—Abdominal pain—Prednisone—systemic scleroderma	0.000861	0.000861	CcSEcCtD
Zanamivir—Body temperature increased—Prednisone—systemic scleroderma	0.000861	0.000861	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00083	0.00083	CcSEcCtD
Zanamivir—Dyspnoea—Methotrexate—systemic scleroderma	0.000812	0.000812	CcSEcCtD
Zanamivir—Hypersensitivity—Prednisone—systemic scleroderma	0.000803	0.000803	CcSEcCtD
Zanamivir—Decreased appetite—Methotrexate—systemic scleroderma	0.000792	0.000792	CcSEcCtD
Zanamivir—Fatigue—Methotrexate—systemic scleroderma	0.000785	0.000785	CcSEcCtD
Zanamivir—Asthenia—Prednisone—systemic scleroderma	0.000782	0.000782	CcSEcCtD
Zanamivir—Pain—Methotrexate—systemic scleroderma	0.000779	0.000779	CcSEcCtD
Zanamivir—Feeling abnormal—Methotrexate—systemic scleroderma	0.00075	0.00075	CcSEcCtD
Zanamivir—Diarrhoea—Prednisone—systemic scleroderma	0.000746	0.000746	CcSEcCtD
Zanamivir—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000745	0.000745	CcSEcCtD
Zanamivir—Urticaria—Methotrexate—systemic scleroderma	0.000723	0.000723	CcSEcCtD
Zanamivir—Dizziness—Prednisone—systemic scleroderma	0.000721	0.000721	CcSEcCtD
Zanamivir—Abdominal pain—Methotrexate—systemic scleroderma	0.00072	0.00072	CcSEcCtD
Zanamivir—Body temperature increased—Methotrexate—systemic scleroderma	0.00072	0.00072	CcSEcCtD
Zanamivir—Vomiting—Prednisone—systemic scleroderma	0.000693	0.000693	CcSEcCtD
Zanamivir—Rash—Prednisone—systemic scleroderma	0.000687	0.000687	CcSEcCtD
Zanamivir—Dermatitis—Prednisone—systemic scleroderma	0.000686	0.000686	CcSEcCtD
Zanamivir—Headache—Prednisone—systemic scleroderma	0.000683	0.000683	CcSEcCtD
Zanamivir—Hypersensitivity—Methotrexate—systemic scleroderma	0.000671	0.000671	CcSEcCtD
Zanamivir—Asthenia—Methotrexate—systemic scleroderma	0.000653	0.000653	CcSEcCtD
Zanamivir—Nausea—Prednisone—systemic scleroderma	0.000647	0.000647	CcSEcCtD
Zanamivir—Diarrhoea—Methotrexate—systemic scleroderma	0.000623	0.000623	CcSEcCtD
Zanamivir—Dizziness—Methotrexate—systemic scleroderma	0.000602	0.000602	CcSEcCtD
Zanamivir—Vomiting—Methotrexate—systemic scleroderma	0.000579	0.000579	CcSEcCtD
Zanamivir—Rash—Methotrexate—systemic scleroderma	0.000574	0.000574	CcSEcCtD
Zanamivir—Dermatitis—Methotrexate—systemic scleroderma	0.000574	0.000574	CcSEcCtD
Zanamivir—Headache—Methotrexate—systemic scleroderma	0.00057	0.00057	CcSEcCtD
Zanamivir—Nausea—Methotrexate—systemic scleroderma	0.000541	0.000541	CcSEcCtD
